Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer’s Disease
Shampa Ghosh, Rakesh Bhaskar, Krishna Kumar Singh, Samarth Sharma, Bhuvaneshwar Yarlagadda, Jitendra Kumar Sinha, Sung Soo Han · 2025
Read Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer’s Disease by Shampa Ghosh, Rakesh Bhaskar, Krishna Kumar Singh, Samarth Sharma, Bhuvaneshwar Yarlagadda, Jitendra Kumar Sinha, Sung Soo Han (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12816493.txt.
Description
Shampa Ghosh and co-authors reviewed in 2025 the immune side of Alzheimer's disease and the AI tools now aimed at it. The modern view casts brain immune dysfunction as a core driver, not a bystander. Resident immune cells misfire, inflammasome alarms stay on, and outside immune cells slip in. The review gathers the molecular and cellular detail behind that picture.
Metabolic rewiring of microglia and their fat handling get special attention as engines of inflammation. Treatments in play range from inflammasome blockers to stem cell vesicles and calming the body's outer immune system. The second half turns to computation: AI models that mine multi-omics data, flag biomarkers, and simulate disease course. The authors argue the two fronts must merge. Precision therapy for Alzheimer's, they say, will be immune-aware and data-driven at once.
Catalog record
| CREATOR | Shampa Ghosh, Rakesh Bhaskar, Krishna Kumar Singh, Samarth Sharma, Bhuvaneshwar Yarlagadda, Jitendra Kumar Sinha, Sung Soo Han |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 79 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |